Onelife Capital (ONELIFECAP)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Price-to-book of 0.21 implies the market values the company at roughly 21% of stated book value
• Book value per share of ₹79.68 provides a theoretical asset cushion against the current price of ₹16.80
• Promoter holding at 52.10% aligns insider interests with minority shareholders to some degree
• Piotroski F-Score of 5/9 indicates some positive financial health signals, though not overwhelmingly strong

Concerns

• Latest quarter shows sales of only ₹1 Cr and a net loss of ₹2 Cr, indicating continued operational weakness
• ROCE at -26.66% and ROE at -0.43% show capital is not being productively deployed
• Sales growth of -61.65% reflects a sharp shrinkage in the core business
• Debt/equity of 1.28 is high for a stockbroking firm with negative earnings, raising asset-quality and solvency risk

AI Analysis

When I look at Onelife Capital, I see a classic Graham-style quantitative bargain, but I must ask whether the figures are too good to be true. The stock trades at ₹16.80 against a book value of ₹79.68 — barely one-fifth of stated net worth. That is a wide discount, and promoter holding of 52.10% suggests insiders have some skin in the game. But a cheap price does not make a good investment. This is a stockbroking business, an industry with thin moats, intense competition, and capital that can evaporate quickly. The latest quarter tells me the operating engine is still losing money: sales of only ₹1 Cr and a net loss of ₹2 Cr. Trailing P/E is zero because there are no earnings to speak of. ROE is negative at -0.43%, and ROCE is deeply negative at -26.66%. That means every rupee of capital employed is destroying value. Sales growth has collapsed by -61.65%, and while profit growth shows +37.50%, on a negative or negligible base that number is meaningless. Debt/equity of 1.28 further tightens my margin of safety. In a stockbroking firm, assets may include client receivables, deposits, or investments whose realizable value can be far lower than book. The Piotroski score of 5/9 is middling, not a clean bill of health. I cannot rely on earnings, so this is an asset play — but only if the book value is real, liquid, and not impaired by hidden liabilities. I would need to see the balance sheet line by line and understand what the ₹79.68 book value is actually composed of. If the net assets can be realized near stated value, the discount may be compelling. But in a business losing money and shrinking, book value can melt away quickly. I would wait, demand a larger margin of safety, and watch debt and operating losses closely.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer